minichart
January 31, 2026
AgomAb Therapeutics NV IPO: In-Depth Investor Analysis, Risks, Financials, and Growth Outlook AgomAb Therapeutics NV Date of Prospectus: 2026 AgomAb Therapeutics NV IPO: Growth-Driven Biotech Debut on Nasdaq Signals Ambitious Expansion AgomAb Therapeutics NV,...